A large observational study of cardiovascular outcomes associated with atorvastatin or simvastatin therapy in diabetic patients without prior cardiovascular disease.
Diabetes Res Clin Pract
; 82(1): e13-5, 2008 Oct.
Article
in En
| MEDLINE
| ID: mdl-18774618
Analysis of claims data from 46,076 diabetic patients without cardiovascular disease initiating atorvastatin or simvastatin therapy suggested that, after adjusting for demographic and clinical confounders, use of atorvastatin was associated with fewer cardiovascular events versus simvastatin at doses of similar potency (HR 0.88, 95% CI 0.80-0.97, P=0.01).
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrroles
/
Cardiovascular Diseases
/
Simvastatin
/
Diabetes Mellitus
/
Heptanoic Acids
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Diabetes Res Clin Pract
Journal subject:
ENDOCRINOLOGIA
Year:
2008
Document type:
Article
Affiliation country:
United States
Country of publication:
Ireland